Overview
Becton, Dickinson and Company, based in the United States, is a global medical technology firm that operates primarily in the healthcare sector. As a leading player in the industry, the company specializes in the development, manufacture, and sale of a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. Key initiatives of Becton, Dickinson and Company include advancing innovations in medication management and infection prevention. Additionally, the company is heavily invested in enhancing diabetes care and pioneering new solutions in areas such as biosciences and diagnostic systems, aiming to improve medical outcomes and patient safety on a global scale. This strategic focus supports its vision to impact worldwide healthcare through technology-driven solutions.
Basic Stats
The share price of Becton Dickinson & Co. 6.125% Preferred Series A as of April 30, 2020 is $59.24 / share.
The Factor Analysis chart (below right) shows a view of Becton Dickinson & Co. 6.125% Preferred Series A from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Becton Dickinson & Co. 6.125% Preferred Series A is $246.11. The forecasts range from a low of $193.29 to a high of $374.50. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Becton Dickinson & Co. 6.125% Preferred Series A. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2012-08-01 | JP Morgan | Neutral | Underweight | Downgrade |
| 2012-07-23 | Citigroup | Neutral | Maintains | |
| 2012-05-02 | Deutsche Bank | Hold | Maintains | |
| 2012-02-08 | Citigroup | Neutral | Maintains | |
| 2024-07-10 | Citigroup | Neutral | Neutral | Maintains |
| 2024-07-02 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-05-30 | Goldman Sachs | Buy | Initiate | |
| 2024-05-06 | Barclays | Overweight | Overweight | Maintains |
| 2024-02-05 | Barclays | Overweight | Overweight | Maintains |
| 2024-01-03 | Raymond James | Outperform | Outperform | Maintains |
| 2023-12-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-10 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-11-10 | Raymond James | Outperform | Outperform | Maintains |
| 2023-08-21 | Citigroup | Neutral | Neutral | Maintains |
| 2023-08-07 | Barclays | Overweight | Overweight | Maintains |
| 2023-08-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-04 | Raymond James | Outperform | Outperform | Maintains |
| 2023-07-24 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-07-24 | Raymond James | Market Perform | Outperform | Upgrade |
| 2023-05-08 | Citigroup | Neutral | Maintains | |
| 2023-05-08 | Barclays | Overweight | Maintains | |
| 2023-05-05 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2023-04-12 | Keybanc | Sector Weight | Overweight | Upgrade |
| 2023-04-04 | Evercore ISI Group | Outperform | Maintains | |
| 2023-02-03 | Morgan Stanley | Overweight | Maintains | |
| 2023-02-03 | Piper Sandler | Neutral | Maintains | |
| 2023-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-03 | B of A Securities | Neutral | Buy | Upgrade |
| 2022-12-12 | Citigroup | Sell | Neutral | Upgrade |
| 2022-11-23 | Goldman Sachs | Buy | Maintains | |
| 2022-11-11 | Piper Sandler | Neutral | Maintains | |
| 2022-10-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-08-16 | Goldman Sachs | Buy | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-11 | Citigroup | Neutral | Sell | Downgrade |
| 2022-06-24 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2022-05-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-05-06 | Piper Sandler | Neutral | Maintains | |
| 2022-04-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-04-01 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-03-28 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-04 | SVB Leerink | Market Perform | Maintains | |
| 2022-01-07 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-08 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-08-06 | JP Morgan | Overweight | Neutral | Downgrade |
| 2021-08-06 | SVB Leerink | Market Perform | Maintains | |
| 2021-05-25 | Barclays | Equal-Weight | Initiate | |
| 2021-05-07 | SVB Leerink | Market Perform | Maintains | |
| 2021-02-05 | Citigroup | Neutral | Maintains | |
| 2021-01-29 | Raymond James | Outperform | Maintains | |
| 2020-12-15 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2020-12-15 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2020-11-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-10-12 | Raymond James | Outperform | Maintains | |
| 2020-08-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-08-10 | UBS | Neutral | Maintains | |
| 2020-08-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-08-07 | Raymond James | Outperform | Maintains | |
| 2020-07-15 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-09 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2020-06-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-06-25 | Raymond James | Outperform | Maintains | |
| 2020-06-01 | Goldman Sachs | Buy | Initiate | |
| 2020-05-14 | Piper Sandler | Overweight | Maintains | |
| 2020-05-08 | CFRA | Hold | Maintains | |
| 2020-05-08 | UBS | Neutral | Maintains | |
| 2020-05-08 | Stifel | Buy | Maintains | |
| 2020-05-08 | SVB Leerink | Market Perform | Reiterate | |
| 2020-05-08 | Raymond James | Outperform | Maintains | |
| 2020-05-08 | Citigroup | Neutral | Maintains | |
| 2020-04-08 | SVB Leerink | Market Perform | Maintains | |
| 2020-04-08 | Wells Fargo | Overweight | Maintains | |
| 2020-04-01 | Stifel | Buy | Maintains | |
| 2020-03-27 | Citigroup | Neutral | Maintains | |
| 2020-03-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-05 | Citigroup | Neutral | Initiate | |
| 2020-02-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-02-07 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2020-02-07 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2020-02-07 | Wells Fargo | Overweight | Maintains | |
| 2020-02-07 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2020-02-06 | CFRA | Buy | Hold | Downgrade |
| 2020-01-22 | KeyBanc | Overweight | Maintains | |
| 2020-01-08 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2019-12-20 | JP Morgan | Overweight | Maintains | |
| 2019-12-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-12-16 | Stifel Nicolaus | Buy | Maintains | |
| 2019-11-13 | KeyBanc | Overweight | Maintains | |
| 2019-11-06 | Wells Fargo | Outperform | Maintains | |
| 2019-09-06 | Wells Fargo | Outperform | Maintains | |
| 2019-07-16 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-06-28 | Raymond James | Strong Buy | Maintains | |
| 2019-05-13 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2019-05-10 | KeyBanc | Overweight | Overweight | Maintains |
| 2019-05-10 | BMO Capital | Market Perform | Maintains | |
| 2019-05-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-05-10 | UBS | Neutral | Maintains | |
| 2019-04-15 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2019-03-19 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2019-01-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2019-01-02 | Citigroup | Buy | Buy | Maintains |
| 2018-12-07 | Deutsche Bank | Buy | Initiate | |
| 2018-11-28 | UBS | Neutral | Initiate | |
| 2018-11-13 | Citigroup | Buy | Buy | Maintains |
| 2018-11-08 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-10-16 | Barclays | Equal-Weight | Initiate | |
| 2018-10-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-08-08 | Citigroup | Buy | Buy | Maintains |
| 2018-06-21 | JP Morgan | Neutral | Overweight | Upgrade |
| 2018-04-10 | Citigroup | Neutral | Buy | Upgrade |
| 2018-03-06 | BMO Capital | Market Perform | Initiate | |
| 2018-02-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-01-05 | KeyBanc | Overweight | Initiate | |
| 2018-01-03 | Evercore ISI Group | Outperform | Initiate | |
| 2017-11-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-10-24 | Wells Fargo | Outperform | Maintains | |
| 2017-09-22 | Wells Fargo | Outperform | Initiate | |
| 2017-08-10 | Barclays | Equal-Weight | Maintains | |
| 2017-06-30 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2017-04-24 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2017-01-05 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2017-01-03 | JP Morgan | Overweight | Neutral | Downgrade |
| 2016-09-23 | Citigroup | Neutral | Sell | Downgrade |
| 2014-08-01 | Barclays | Underweight | Maintains | |
| 2014-08-01 | JP Morgan | Underweight | Maintains | |
| 2014-06-30 | Barclays | Underweight | Maintains | |
| 2013-06-25 | ISI Group | Buy | Initiate | |
| 2013-06-24 | ISI Group | Buy | Initiate | |
| 2014-02-05 | Raymond James | Underperform | Market Perform | Upgrade |
| 2014-01-07 | Bank of America | Underperform | Neutral | Upgrade |
| 2013-11-06 | Jefferies | Buy | Maintains | |
| 2013-09-18 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2012-08-03 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2013-08-02 | Deutsche Bank | Hold | Maintains | |
| 2012-08-02 | Canaccord Genuity | Hold | Maintains | |
| 2013-05-10 | Macquarie | Neutral | Outperform | Upgrade |
| 2013-04-12 | Deutsche Bank | Hold | Maintains | |
| 2013-03-28 | Jefferies | Buy | Maintains | |
| 2013-01-22 | Mizuho | Buy | Neutral | Downgrade |
| 2016-08-05 | UBS | Buy | Maintains | |
| 2016-07-28 | Jefferies | Buy | Maintains | |
| 2016-02-11 | Deutsche Bank | Hold | Buy | Upgrade |
| 2016-02-04 | Citigroup | Neutral | Maintains | |
| 2016-01-06 | Evercore ISI Group | Buy | Hold | Downgrade |
| 2016-01-04 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2015-11-12 | Citigroup | Neutral | Initiate | |
| 2015-08-10 | Deutsche Bank | Hold | Maintains | |
| 2015-08-07 | JP Morgan | Overweight | Maintains | |
| 2015-03-10 | UBS | Neutral | Initiate | |
| 2015-03-04 | JP Morgan | Overweight | Maintains | |
| 2015-02-06 | Deutsche Bank | Hold | Maintains | |
| 2015-01-05 | Raymond James | Market Perform | Strong Buy | Upgrade |
| 2014-11-26 | JP Morgan | Neutral | Overweight | Upgrade |
| 2014-11-26 | Deutsche Bank | Hold | Maintains | |
| 2014-11-05 | Bank of America | Neutral | Maintains | |
| 2014-10-14 | Bank of America | Neutral | Maintains | |
| 2014-10-07 | Argus | Buy | Maintains | |
| 2014-10-07 | Canaccord Genuity | Hold | Maintains | |
| 2014-10-07 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2014-10-06 | JP Morgan | Underweight | Neutral | Upgrade |
| 2012-08-03 | Deutsche Bank | Hold | Maintains | |
| 2013-01-04 | Deutsche Bank | Hold | Maintains | |
| 2013-01-03 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
| 2012-11-20 | Stifel Nicolaus | Hold | Initiate | |
| 2012-11-07 | Canaccord Genuity | Hold | Maintains | |
| 2012-10-16 | Citigroup | Neutral | Maintains | |
| 2012-09-24 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2012-08-03 | Barclays | Equal-Weight | Maintains | |
| 2012-08-03 | CLSA | Outperform | Underperform | Downgrade |
| 2025-05-02 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2025-05-02 | Stifel | Buy | Buy | Maintains |
| 2025-05-01 | William Blair | Outperform | Market Perform | Downgrade |
| 2024-07-26 | Stifel | Buy | Buy | Maintains |
| 2024-10-01 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-01-28 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-04-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-02 | Raymond James | Outperform | Outperform | Maintains |
| 2025-08-08 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-04-23 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-14 | Barclays | Overweight | Overweight | Maintains |
| 2024-10-01 | Citigroup | Neutral | Buy | Upgrade |
| 2025-05-22 | Citigroup | Buy | Neutral | Downgrade |
| 2025-06-03 | Barclays | Overweight | Overweight | Maintains |
| 2025-08-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-08-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-06 | Morgan Stanley | Overweight | Overweight | Maintains |
